Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-59,887
Closed -$13.7M 298
2021
Q2
$13.7M Sell
59,887
-30,941
-34% -$6.22M 0.59% 56
2021
Q1
$17M Sell
90,828
-17,311
-16% -$3.39M 0.59% 53
2020
Q4
$18.2M Buy
108,139
+42,221
+64% +$6.3M 0.55% 64
2020
Q3
$9.73M Sell
65,918
-16,682
-20% -$2.58M 0.24% 105
2020
Q2
$13.5M Sell
82,600
-4,000
-5% -$614K 0.49% 42
2020
Q1
$12M Hold
86,600
0.51% 44
2019
Q4
$11.4M Sell
86,600
-700
-0.8% -$81.1K 0.38% 59
2019
Q3
$9.76M Sell
87,300
-1,700
-2% -$189K 0.36% 68
2019
Q2
$9.86M Sell
89,000
-1,971
-2% -$232K 0.36% 68
2019
Q1
$11.8M Sell
90,971
-31,029
-25% -$3.77M 0.46% 58
2018
Q4
$14.1M Hold
122,000
0.59% 38
2018
Q3
$13.1M Hold
122,000
0.4% 65
2018
Q2
$10.4M Buy
122,000
+9,000
+8% +$739K 0.34% 74
2018
Q1
$8.74M Hold
113,000
0.32% 83
2017
Q4
$9.55M Hold
113,000
0.34% 74
2017
Q3
$9.66M Hold
113,000
0.34% 77
2017
Q2
$9.3M Hold
113,000
0.34% 87
2017
Q1
$9.5M Buy
113,000
+43,000
+61% +$3.44M 0.36% 77
2016
Q4
$5.15M Sell
70,000
-45,000
-39% -$3.35M 0.19% 144
2016
Q3
$9.23M Hold
115,000
0.36% 79
2016
Q2
$9.05M Hold
115,000
0.36% 86
2016
Q1
$8.28M Hold
115,000
0.33% 93
2015
Q4
$9.69M Sell
115,000
-19,000
-14% -$1.58M 0.4% 80
2015
Q3
$11.2M Hold
134,000
0.5% 65
2015
Q2
$11.2M Sell
134,000
-110,000
-45% -$8.38M 0.42% 74
2015
Q1
$17.7M Hold
244,000
0.56% 45
2014
Q4
$16.8M Buy
244,000
+44,000
+22% +$2.97M 0.43% 55
2014
Q3
$13M Buy
200,000
+27,000
+16% +$1.71M 0.37% 58
2014
Q2
$10.8M Hold
173,000
0.34% 66
2014
Q1
$10.2M Buy
173,000
+68,000
+65% +$3.8M 0.34% 71
2013
Q4
$5.36M Sell
105,000
-15,000
-13% -$751K 0.2% 131
2013
Q3
$6.04M Sell
120,000
-55,000
-31% -$2.88M 0.36% 109
2013
Q2
$8.59M Buy
+175,000
New +$9.52M 0.52% 85

Other funds holding LLY

BP's LLY Position: Q3 2021 in Review

BP sold out of Eli Lilly (LLY) in Q3 2021, closing a stake of 59,887 shares — an estimated $13.7M sold.

BP first reported a position in LLY in Q2 2013 and held it in 33 quarters. The position peaked at $18.2M in Q4 2020. 2,050 funds tracked by Wall St. Rank hold LLY as of Q3 2021.

  • BP reported no remaining Eli Lilly position as of Q3 2021 after selling out during the quarter.
  • BP sold 59,887 Eli Lilly shares in Q3 2021, an estimated $13.7M.
  • BP first reported a position in Eli Lilly in Q2 2013 and held it in 33 quarters.
  • BP's Eli Lilly position peaked at $18.2M in Q4 2020.
  • 2,050 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2021.

Based on BP's 13F filing for Q3 2021, filed 10 Nov 2021.